InvestorsHub Logo
Followers 40
Posts 1803
Boards Moderated 1
Alias Born 10/31/2012

Re: Paulness post# 5243

Tuesday, 09/30/2014 9:25:32 AM

Tuesday, September 30, 2014 9:25:32 AM

Post# of 24335
A buyout would be interesting. They are building a strong team to position the product, develop distribution channels, and are also looking at other ways to use the technology (narcotics).

We have a walk off home run here IMO.

Peters is a former Federal Prosecutor - a modern day untouchable. "Among other things, he will be involved in exploring possible applications of the Company’s technology to narcotics detection."

Rollins - "He has advised Fortune 400 chief executives and leaders of major trade associations on corporate reputation, crisis management, advertising, public relations, and governmental affairs."

"Mr. van Bijleveld has been instrumental in the development of top-performing global businesses in diagnostics, pharmaceuticals and biotechnology industries in over 30 countries, reflecting his experience in general management, marketing and sales management, acquisitions, operational excellence, and licensing and business development."

Steinhubl - "Dr. Steinhubl is director of digital medicine at the Scripps Translational Science Institute, and a practicing cardiologist at the integrated Scripps Health system, both in San Diego. Dr. Steinhubl is working to lead the clinical transformation of healthcare by enabling the evidence driven adoption of mobile health technologies through the design and management of pragmatic clinical trials."

Just keeps getting better and better.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VNTH News